会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 111. 发明公开
    • DETERRING ABUSE OF PHARMACEUTICAL PRODUCTS AND ALCOHOL
    • VERHINDERUNG DES MISSBRAUCHS VON PHARMAZEUTISCHEN PRODUKTEN UND ALKOHOL
    • EP3038604A2
    • 2016-07-06
    • EP14842598.6
    • 2014-09-09
    • Nova Southeastern University
    • OMIDIAN, HosseinMASTROPIETRO, David, J.MUPPALANENI, Srinath
    • A61K9/20A61K9/24
    • A61K31/135A61K9/10A61K9/143A61K9/1676A61K9/2009A61K9/2027A61K9/2054A61K9/2059A61K9/2086A61K47/02A61K47/10A61K47/32A61K47/48015A61K47/4823A61K47/52A61K47/61
    • A therapeutic dosage form includes a pharmaceutically active ingredient, a crosslinked polyacid, and a linear polyacids. The crosslinked polyacid is insoluble in water, and the linear polyacid is soluble in water. An example of a crosslinked polyacids is sodium carboxymethylcellulose. The linear polyacid possesses sufficient binding sites to form a stable complex with the pharmaceutically active ingredient. An example of a linear polyacid is polymethacrylic acid. The ingredients are formed into a tablet or capsule, either admixed, in layers, or separated by a coating. Abuse is deterred in that crushing causes the active ingredient to be bound and not abusable, and placing the dosage in solution causes a strong complex to be formed between the polyacid and the active ingredient, including a solution with ethanol. Other therapeutic dosage forms for reducing the incidence of tampering and abuse of pharmaceutical products and alcohol, and specifically preventing the isolation and concentration of drug constituents for misuse, and preventing excessive intake are also disclosed.
    • 治疗剂型包括药物活性成分,交联多酸和线性多元酸。 交联的多酸不溶于水,线性多元酸可溶于水。 线性多元酸具有足够的结合位点以与药物活性成分形成稳定的复合物。 成分形成片剂或胶囊,混合,分层,或由涂层分开。 阻止滥用是因为破碎导致活性成分结合而不可滥用,并将剂量置于溶液中导致在多酸和活性成分之间形成强烈的复合物,包括用乙醇溶液。 还公开了用于降低药物和酒精的篡改和滥用的发生率的其它治疗剂型,并且具体地防止滥用药物成分的分离和浓缩以及防止过度摄入。